The needle is the easy part. Really.
If you've just mixed your first vial, you're probably staring at an insulin syringe and wondering how to inject retatrutide without wasting a dose or doing it wrong. Most people expect the shot to hurt, and it barely registers. The real questions are where to inject retatrutide, how many units to draw, and what to do when you miss a week. This guide answers each one, using the FDA-approved instructions for its closest relatives, tirzepatide and semaglutide, as the rulebook.
🔑 Key Takeaways
- Three sites work: the abdomen, the front of the thighs and the back of the upper arms. One of them is best left to someone else.
- The most common error is not the injection. It is reading the syringe.
- Time of day does not matter. Picking one day and keeping it does.
- The approved labels give a clear rule for a missed dose, and it is more forgiving than most people think.
- Some skin symptoms on retatrutide have nothing to do with where you injected.
Retatrutide has no FDA approval and no official Instructions for Use yet. So we lean on the closest thing that exists: the label instructions for Zepbound (tirzepatide, also from Eli Lilly, also once weekly, with a similar half-life) and Wegovy (semaglutide). Where reta-specific data exists, we use it and say so.
How to Inject Retatrutide: The 60-Second Version
Here is the whole routine at a glance.
- Wash your hands and draw your dose in units on a new U-100 insulin syringe.
- Pick a site: the abdomen (2 inches from the navel), the front of a thigh, or the back of an upper arm if someone else is injecting.
- Clean the skin, let it dry, and pinch a fold if you're lean.
- Insert at 90 degrees (45 if very lean), push the plunger, and hold at least 5 seconds.
- Drop the syringe in a sharps container without recapping.
Same day each week, a new spot each time. The rest of this page covers the parts people get wrong.
Where to Inject Retatrutide: 3 Sites From the Approved Labels
The fat just under your skin is the target.
Retatrutide is given subcutaneously, into that layer of fat between skin and muscle, not into the muscle itself. The phase 2 obesity trial in the New England Journal of Medicine gave 338 adults subcutaneous injections once a week for 48 weeks, the phase 1 study before it used weekly subcutaneous shots too, and the phase 3 TRIUMPH-1 registration lists the same route. [1][2][8]
For the exact sites, the Zepbound label is the best guide. It says you or another person may inject into the stomach (abdomen) or thigh, and that another person can inject into the back of the upper arm. [3] The Wegovy instructions add the detail most guides skip: on the stomach, keep 2 inches away from your belly button. [4]
Is one site better? For semaglutide, the label states the injection site can be changed without any dose change. [4] There's no retatrutide data comparing sites, so pick the one you can reach comfortably and see clearly. For most people that's the belly.
Places to avoid: skin that is tender, bruised, red, scaly or hard, plus scars, stretch marks and any spot with lumps or pits. [3][4] Don't inject through clothing, and don't use the buttocks or the inner thigh unless a clinician has shown you how.
How to Rotate Injection Sites
Rotation sounds fussy. It prevents a real problem.
The Zepbound label tells you to rotate within the area you choose for each dose, to cut the risk of lipodystrophy (pits or thickened skin) and localized cutaneous amyloidosis (skin with lumps). [3] Diabetes injection guidelines add that these lumpy patches distort how medicine is absorbed. [5]
The Wegovy instructions put it simply: you can use the same body area each week, but not the same spot. [4] A system that works:
- Think of the abdomen as four squares around the navel: upper left, upper right, lower left, lower right. Use a different square each week.
- Move at least an inch from last week's spot inside a square.
- Add the thighs if you want more space, and log the site with the date in your phone.
- Keep other injections apart. The Zepbound label says not to inject in the same site used for other medicines. [3]
What You Need Before the First Shot
The kit is small. One item matters more than the rest.
- Mixed retatrutide vial. If you haven't mixed it yet, the retatrutide reconstitution guide walks through it. Short version: add bacteriostatic water slowly down the vial wall, swirl, never shake, then refrigerate.
- U-100 insulin syringes. This is the one that matters. "U-100" means 100 units equal 1 mL, and every unit count on this page assumes it. Sizes are 0.3 mL (30 units), 0.5 mL (50 units) and 1 mL (100 units).
- Alcohol swabs for the stopper and the skin.
- Gauze or a cotton ball for any small bleed.
- A sharps container. The Zepbound vial instructions list it with the syringe, swab and gauze as standard supplies. [3]
Pick the smallest syringe that holds your dose. A 2 mg dose of 20 units on a 0.3 mL syringe has bigger markings than the same dose on a 1 mL barrel, and many 0.3 mL syringes show half units.
Drawing Your Dose: Units on a U-100 Syringe
This is where most dosing errors start.
Your syringe counts units of volume, not milligrams. How many milligrams sit in each unit depends on how much water went into the vial. Using our house mixing standard, a 10 mg vial plus 2 mL of bacteriostatic water gives 5 mg/mL, and a 30 mg vial plus 3 mL gives 10 mg/mL. Here's what that means for a reta dose at common weekly amounts.
The 28-day limit is worth a moment, because it changes which vial makes sense. Once mixed, retatrutide should be refrigerated and used within 28 days. At 2 mg a week, a 10 mg vial empties in 5 doses, right on that line, while a 30 mg vial holds 15 doses you can't use in time. At 8 mg and above it flips: a 10 mg vial gives one dose with leftovers, and at 12 mg only the 30 mg vial covers it. That's worth knowing before you look at retatrutide where to buy options, since the right vial size depends on your dose. Ascension's R-10 (10 mg) is $50 and the R-30 (30 mg) is $125 with code PEPTIDEDECK, and you can compare both on our page to buy retatrutide. Whichever you choose, ask for a lab report for the exact batch. PeptideDeck may earn a commission from these links.
For doses that aren't in the table, or a different amount of water, the retatrutide dosage calculator does the math. Which dose you should be on, and when to step up, is covered in the retatrutide dosing schedule.
To draw, the Zepbound vial instructions use a trick that works for any vial: pull air into the syringe equal to your dose, push it into the vial, then turn the vial upside down and draw slowly past your line. Tap out bubbles and push back to the exact mark. [3]
Step-by-Step: Injecting Retatrutide With an Insulin Syringe
Slow is smooth here.
These steps follow the FDA-approved Zepbound vial Instructions for Use, adjusted for an insulin syringe with a fixed needle. [3]
- Wash your hands and check the vial. The solution should be clear. Don't use it if it's cloudy, has particles, or was frozen. [3]
- Wipe the rubber stopper with an alcohol swab.
- Draw your dose using the air trick above, and check the units twice against the table.
- Clean the injection site with alcohol and let it air-dry. Wet alcohol stings when the needle goes in.
- Pinch a fold of skin between thumb and finger if you're lean or using a longer needle.
- Insert the needle in one quick, smooth motion, like a dart.
- Push the plunger steadily until it stops.
- Hold the needle in for at least 5 seconds so the full dose goes in. [3]
- Pull straight out and let go of the pinch. If you see blood, press with gauze. Don't rub. [3]
- Don't recap. Put the syringe straight into a sharps container. [3]
A drop of liquid on the skin afterward usually means the needle came out too soon. Count to ten next time.
If you inject anything else, such as cagrilintide in a retatrutide and cagrilintide stack, use a separate syringe and a separate spot. The Zepbound label says not to mix it with any other medicine. [3]
Needle Size, Angle and Whether to Pinch
Shorter needles are the modern default.
Injection-technique recommendations from 183 diabetes experts in 54 countries, published in Mayo Clinic Proceedings, call the shortest needles (4 mm pen, 6 mm syringe) safe, effective, less painful and the first-line choice for every patient group, and warn against injecting into muscle. [5] They were written for insulin, which targets the same fat layer.
- Gauge: 29 to 31 gauge insulin syringes are standard. Higher numbers are thinner.
- Length: 6 mm (15/64 in) is the shortest syringe needle and suits most adults. 8 mm and 12.7 mm (1/2 in) syringes are common too.
- Angle: 90 degrees with a 6 mm needle. With 8 mm or longer, or if you're very lean, pinch a fold or go in at 45 degrees so you stay out of muscle.
- Pinch: the Zepbound label leaves pinching to your clinician. [3] A fold is a good habit on the thigh and arm, where the fat layer is often thinner than on the belly.
New to injections in general? Our guide on how to inject peptides covers needle handling and skin prep for any injectable peptide.
Best Time to Take Retatrutide: Morning or Night?
The clock matters less than the calendar.
There's no retatrutide data comparing morning and evening doses. Its half-life is about 6 days, measured in the first human study, which is why it's dosed weekly. [2] The approved relatives settle the time-of-day question: both Zepbound and Wegovy are taken once weekly at any time of day, with or without meals. [3][4] The Wegovy label adds that time of day can change without a dose adjustment. [4]
So choose by side effects and routine.
- Evening suits people who get queasy in the first day after a dose, since some of that window passes while asleep.
- Morning suits people who'd rather notice how they feel and react while awake.
- The day matters more. Many people pick one ahead of a lighter day, so the toughest stretch doesn't land on a busy workday.
Need to move your injection day? The tirzepatide label allows it as long as there are at least 3 days (72 hours) between two doses. [6]
Missed a Dose? The 4-Day Rule
It happens to everyone eventually.
Retatrutide has no label of its own, so the Zepbound label is the closest model. It's a Lilly drug with a similar half-life of about 5 days. [6] Its rule:
- Within 4 days (96 hours) of the missed day: take it as soon as you remember, then go back to your usual day.
- More than 4 days: skip it and take the next dose on your regular day. [6]
- Never double up to catch up.
Semaglutide's rule is stricter: take a missed Wegovy dose only if the next one is more than 2 days away. [4] The Wegovy label also says that after 2 or more missed doses in a row, dose escalation should restart at a lower dose to limit stomach side effects. [4] The same caution makes sense for retatrutide, so talk to your clinician before restarting at your old dose. Our dosing schedule covers missed doses and schedule changes.
Injection-Site Reactions (and a Skin Effect That Isn't One)
A little redness is common. A lot is not.
For a sense of scale, look at the approved drugs. In the Zepbound weight loss trials, injection-site reactions (bruising, redness, itching, pain or rash at the spot) affected 6% to 8% of people on the drug against 2% on placebo. [6] On Wegovy, the figure was 1.4% against 1%. [4] The phase 2 retatrutide abstract named gastrointestinal effects as the most common problems and didn't single out injection-site reactions. [1]
What's normal: a small pink mark, mild itch or a tiny bruise that fades within a day or two. What isn't: redness that keeps spreading, warmth, pus, fever, or a hard lump that grows. Those can mean infection and need a doctor. Hives, swelling of the face or throat, or trouble breathing are an emergency.
One retatrutide effect confuses people. Lilly reports dysesthesia, described as a skin burning sensation, across its phase 3 TRIUMPH trials: 5%, 12% and 13% at 4, 9 and 12 mg in TRIUMPH-1, and 4%, 6% and 7% in TRIUMPH-2, against 1% on placebo, mostly mild to moderate. [7] Lilly's summary doesn't tie it to the injection spot, so don't expect better technique to prevent it. If you feel burning or odd sensations away from where you injected, tell your clinician. The full list is in our retatrutide side effects guide, and the bigger question is covered in is retatrutide safe.
How to Throw Away Used Syringes
The last step is the one people skip.
The Zepbound instructions are specific. Put used needles and syringes in an FDA-cleared sharps container right away, and never throw loose needles in household trash. If you don't have one, use a heavy-duty plastic container with a tight, puncture-resistant lid that stands upright, doesn't leak, and is labelled as hazardous waste. [3] An empty laundry detergent bottle often fits that description.
When it's nearly full, follow your local rules. Some areas have drop-off sites or mail-back programs. Don't recycle it. The FDA keeps a state-by-state guide at fda.gov/safesharpsdisposal. [3]
6 Common Retatrutide Injection Mistakes
Most of these show up in the first month.
The first one causes the biggest problems. A person who draws 20 units from a 10 mg vial mixed with 2 mL gets 1 mg, not 2 mg. Someone who draws 40 units from a 30 mg vial mixed with 3 mL gets 4 mg, double the usual first dose. If you change vial size or water volume, redo the math before the next injection.
Frequently Asked Questions
Sources
- Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial. N Engl J Med. 2023;389:514-526. Funded by Eli Lilly. PMID 37366315. pubmed.ncbi.nlm.nih.gov/37366315
- Urva S, et al. LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b trial. Lancet. 2022;400:1869-1881. PMID 36354040. pubmed.ncbi.nlm.nih.gov/36354040
- Eli Lilly and Company. Zepbound (tirzepatide) single-dose vial Instructions for Use, revised April 2026. pi.lilly.com/us/zepbound-vial-us-ifu.pdf
- Novo Nordisk. Wegovy (semaglutide) Prescribing Information, Patient Information and Instructions for Use, revised June 2026. novo-pi.com/wegovy.pdf
- Frid AH, et al. New Insulin Delivery Recommendations. Mayo Clin Proc. 2016;91(9):1231-1255. PMID 27594187. pubmed.ncbi.nlm.nih.gov/27594187
- Eli Lilly and Company. Zepbound (tirzepatide) Prescribing Information, revised August 2026 (sections 2.3, 6.1, 12.3). pi.lilly.com/us/zepbound-uspi.pdf
- Lilly Medical. Was dysesthesia reported as an adverse event in the retatrutide TRIUMPH trials? Last reviewed August 18, 2026. medical.lilly.com
- ClinicalTrials.gov. A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight (TRIUMPH-1), NCT05929066. clinicaltrials.gov/study/NCT05929066
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Retatrutide has no FDA approval, and the injection guidance above is adapted from the approved labels for tirzepatide and semaglutide. Always consult a qualified healthcare provider before starting any new medication or treatment. PeptideDeck may earn a commission from affiliate links at no additional cost to you.
